The Japan Times - Once-taboo ketamine booms for US at-home mental care

EUR -
AED 4.121845
AFN 72.380179
ALL 91.461825
AMD 404.477538
ANG 2.008512
AOA 1030.187345
ARS 1734.544678
AUD 1.620062
AWG 2.022781
AZN 1.894695
BAM 1.961461
BBD 2.260123
BDT 139.37222
BGN 1.961431
BHD 0.423294
BIF 3378.970171
BMD 1.122209
BND 1.436245
BOB 13.33631
BRL 6.187189
BSD 1.122138
BTN 105.321953
BWP 15.418497
BYN 3.359997
BYR 21995.289057
BZD 2.256913
CAD 1.584587
CDF 2570.979996
CHF 0.919599
CLF 0.027658
CLP 1088.531204
CNY 7.488274
CNH 7.484761
COP 3679.65475
CRC 508.266827
CUC 1.122209
CUP 26.931723
CVE 110.677843
CZK 24.335117
DJF 199.438761
DKK 7.475177
DOP 68.062211
DZD 152.66299
EGP 60.468302
ERN 16.833129
ETB 180.896133
FJD 2.526428
FKP 0.840299
GBP 0.834805
GEL 2.912115
GGP 0.840299
GHS 13.113016
GIP 0.840299
GMD 83.043172
GNF 9945.569235
GTQ 8.574708
GYD 235.247863
HKD 8.800399
HNL 30.383836
HRK 7.596241
HTG 147.084477
HUF 362.122693
IDR 20291.776364
ILS 3.544821
IMP 0.840299
INR 105.089058
IQD 1699.023859
IRR 2134761.219536
ISK 137.313761
JEP 0.840299
JMD 178.26446
JOD 0.795636
JPY 177.220871
KES 145.842481
KGS 98.137042
KHR 4584.222231
KMF 496.015853
KPW 1009.987719
KRW 1504.118278
KWD 0.348816
KYD 0.935191
KZT 503.462963
LAK 25255.305476
LBP 100493.782176
LKR 373.115125
LRD 191.108694
LSL 18.583762
LTL 3.31359
LVL 0.678813
LYD 7.215948
MAD 10.94995
MDL 20.227194
MGA 5156.548602
MKD 61.554925
MMK 2356.028074
MNT 4041.259556
MOP 9.063256
MRU 45.168408
MUR 52.833791
MVR 17.28467
MWK 1949.276163
MXN 20.822022
MYR 4.554818
MZN 71.707157
NAD 18.583439
NGN 1511.614981
NIO 41.084377
NOK 10.542578
NPR 168.515325
NZD 1.992268
OMR 0.431497
PAB 1.122239
PEN 3.863199
PGK 5.040964
PHP 70.789038
PKR 310.459367
PLN 4.38572
PYG 7014.242675
QAR 4.088167
RON 5.343396
RSD 117.659066
RUB 92.582187
RWF 1655.257722
SAR 4.219971
SBD 9.032189
SCR 15.623069
SDG 675.019877
SEK 10.993279
SGD 1.435153
SHP 0.840448
SLE 25.754353
SLL 23532.158705
SOS 641.341166
SRD 42.141205
STD 23227.452815
STN 24.997197
SVC 9.819338
SYP 14590.956193
SZL 18.584279
THB 37.498655
TJS 10.301383
TMT 3.92773
TND 3.350359
TOP 2.702009
TRY 56.31176
TTD 7.610965
TWD 36.778701
TZS 2968.239571
UAH 51.121935
UGX 4595.261644
USD 1.122209
UYU 45.250388
UZS 13466.503672
VES 1005.853999
VND 28633.71418
VUV 133.836923
WST 3.12852
XAF 655.957
XAG 0.021049
XAU 0.000271080273
XCD 3.032825
XCG 2.022437
XDR 0.79346
XOF 655.957
XPF 119.331742
YER 265.542618
ZAR 18.387053
ZMK 10101.226587
ZMW 22.807822
ZWL 361.35072
SSP 6447.349269
MXV 2.340764
  • RYCEF

    0.1000

    19.81

    +0.5%

  • VOD

    -0.2500

    16.33

    -1.53%

  • CMSC

    -0.2800

    20.12

    -1.39%

  • RBGPF

    -2.0000

    65

    -3.08%

  • RIO

    -0.2500

    94.16

    -0.27%

  • BTI

    -1.2000

    54.85

    -2.19%

  • NGG

    -0.3000

    74.94

    -0.4%

  • GSK

    -0.3500

    49.35

    -0.71%

  • BCE

    -0.4200

    20.14

    -2.09%

  • CMSD

    -0.3400

    19.93

    -1.71%

  • BP

    -0.9100

    43.52

    -2.09%

  • RELX

    0.1700

    33.24

    +0.51%

  • BCC

    -0.6200

    75.97

    -0.82%

  • AZN

    -1.9400

    164.21

    -1.18%

  • JRI

    0.0000

    10.77

    0%

Once-taboo ketamine booms for US at-home mental care
Once-taboo ketamine booms for US at-home mental care

Once-taboo ketamine booms for US at-home mental care

Americans are paying to get a star of the psychedelic medicine movement –- ketamine -– shipped to them for at-home mental health treatments that are being called both a breakthrough and a gamble.

Text size:

A pandemic-spurred easing of prescription rules helped fuel a jump in telemedicine offerings of ketamine, an anesthetic that was once a taboo party drug but has become a buzzed-about tool against depression.

Yet long-term, large-scale studies of ketamine's medical impact are limited, leaving some experts concerned that an unregulated online boom could result in mishaps or a regulatory crackdown.

"This has to be rolled out slowly," said Boris Heifets, a Stanford University assistant professor of anesthesiology. "The risk is that we are scaling the fix but not the solution, which is a much more integrated approach to mental health."

Ketamine has been available in the United States since the 1970s as an anesthetic called a "dissociative" because of the hallucinogenic effects that have helped make it a rave culture drug.

It's legal for US doctors to prescribe, while some other psychedelics getting renewed attention for mental health uses like LSD or MDMA (also called ecstasy) are classified as having no medical utility and a high risk for abuse.

In this context, recent years have seen an uptick in clinics offering in-person intravenous ketamine treatments for depression, anxiety or chronic pain, though regulations and practices vary across American states.

- Ketamine 'babysitter' -

Then came the pandemic, which resulted in US authorities allowing doctors to remotely prescribe drugs like ketamine that previously required an in-person visit.

An increasing number of companies, some already doing in-clinic treatments, began offering to evaluate clients online and to send the drugs for home use to approved candidates.

Nue Life, which launched about a year ago, is one of those firms. Its CEO Juan Pablo Cappello estimated it has served over 3,000 ketamine patients so far.

"If you actually drill down on the sort of potentials for abuse here, you realize of course they exist, but we're creating a standard of care to make that quite unlikely," he told AFP.

For example, he noted clients are instructed to have an adult "babysitter" watch over them for the roughly 90 minutes the drug experience lasts, and he reasoned that people simply looking for ketamine could get it cheaper on the street.

Clients of the service, which costs $1,250 for a package providing six ketamine experiences, are encouraged but not obligated to couple it with therapy, Cappello said.

"The at-home telemedicine model, I would argue, is actually safer and more effective for patients," allowing more patients "to actually take advantage of these therapies," he added.

Heifets, the Stanford researcher, noted that making ketamine more available carries risks -- including the chances that authorities would tighten access if an at-home treatment resulted in some sort of tragedy.

- 'Change your life' -

US regulators in 2019 approved a type of ketamine specifically for adults with treatment-resistant depression, though with stringent rules like requiring patients to be monitored by a health care provider for at least two hours after their dose.

Americans have "a hair trigger for problem-solving through litigation," Heifets noted of the potential for lawsuits if things go wrong.

He was part of a team that analyzed the real-world effectiveness of intravenous ketamine therapy -- which can involve higher doses than the at-home services –- and reported most patients improved, though about eight percent said depressive symptoms worsened after treatment.

"We have very, very little evidence for our understanding of how effective ketamine is for depression at scale," he added.

Yet for people like 36-year-old New Yorker Philip Markle, who underwent an at-home treatment with a company called Mindbloom, ketamine is a profoundly useful tool.

Over his long battle with depression, the performer and comedian has tried medication, psychedelics like LSD, and talk therapy since the age of 12, but found something unique in ketamine.

Rather than the short-lived sense of change other treatments provided, ketamine imparted a sense of clarity and of helpful self-acceptance -– not the heavy effects he'd experienced with other psychedelics.

"It felt like if any drug could be administered through the mail, and you could do a psychedelic that could change your life, on your own, this would be the one," he told AFP.

M.Yamazaki--JT